Article Text

Download PDFPDF
Progressive supranuclear palsy finally has a clinically measureable τ abnormality

Statistics from Altmetric.com

Footnotes

  • The hunt for objective biomarkers for neurodegenerative disorders is starting to pay dividends, with a reduction rather than increase in CSF τ levels identified by Wagshal et al1 in patients with progressive supranuclear palsy (PSP).

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • General neurology
    Dana Wagshal Sethu Sankaranarayanan Valerie Guss Tracey Hall Flora Berisha Iryna Lobach Anna Karydas Lisa Voltarelli Carole Scherling Hilary Heuer Maria Carmela Tartaglia Zachary Miller Giovanni Coppola Michael Ahlijanian Holly Soares Joel H Kramer Gil D Rabinovici Howard J Rosen Bruce L Miller Jere Meredith Adam L Boxer